货号：UP737200850
| 产品信息 | |
| 产品名称： | IKKε-IN-1 |
| 中文名称： | (请以英文为准,中文仅做参考) |
| CAS号： | 1292310-49-6 |
| 分子式： | C26H27N5O3 |
| 分子量： | 457.52 |
| MDL NO： | MFCD28167836 |
| 标准纯度： | 98+% (UP737200850) |
| 沸点： | - |
| 储存： | (UP737200850) |
| Pubchem ID： | - |
| ACS编号： | - |
| InChIKey： | - |
| Clogp | - |
| 英文别名： | - |
| 中文别名 | - |
抑制剂/受体激动剂
核因子κa-活化B细胞的轻链增强子
NF-κB
抑制剂/受体激动剂
核因子κa-活化B细胞的轻链增强子
β-D-glucosidase
抑制剂/受体激动剂
核因子κa-活化B细胞的轻链增强子
NOD1
BC2059
UP5207980791227637-23-1
Bay 65-1942 hydrochloride
UP207824864600734-06-3
PS48
UP6618910071180676-32-7
SKL2001
UP676770998909089-13-0
Benzocaine
UP42146024094-09-7
Temsirolimus
UP548131079162635-04-3
PKC412
UP373819596120685-11-2
IMD-0354
UP354884239978-62-1
BX795
UP186999293702675-74-9
((4R,5R)-2,2-Dimethyl-1,3-dioxolane-4,5-diyl)bis(methylene) bis(4-methylbenzenesulfonate)
UP72818560051064-65-4
Cycloheptylmethanamine hydrochloride
UP239854370177352-26-0
SC514
UP213373567354812-17-2
3,5-Difluoro-2-hydroxybenzaldehyde
UP63759500263954-77-8
GSK1904529A
UP3267917321089283-49-7
PF-06463922
UP5198586791454846-35-5
KN-62
UP413693883127191-97-3
SRPIN340
UP127423726218156-96-8
Apatinib
UP389135261811803-05-1
1,2-Diiodo-3-fluorobenzene
UP948622922501433-02-9
BCX 1470 methanesulfonate
UP235469088217099-44-0
T338C Src-IN-2
UP6192664771351927-00-8
3-Iodo-6-nitro-1H-indazole
UP25232696170315-70-7
AG1024
UP48717231165678-07-1
CZ415
UP5189879471429639-50-8
PP121
UP8906660591092788-83-4
Heliosterpenoid A
UP2876449242109805-68-5
Necrostatin 2 S-Enantiomer
UP968802750852391-20-9
Regorafenib HCl
UP839392593835621-07-3
HG-14-10-04
UP4291322451356962-34-9
4,4,4-Trifluoro-1-(p-tolyl)butane-1,3-dione
UP641244838720-94-5
KN-93
UP437289635139298-40-1
MCB-613
UP6922091901162656-22-5
ZM323881
UP914441939193001-14-8
2-Chlorotrityl Chloride Resin 100-200 mesh, 1% DVB
UP9772917704934816-82-7
PDK1 inhibitor
UP7852071181001409-50-2
E-6446 Dihydrochloride
UP3274555571345675-25-3
(1S,2S)-N,N'-Dimethylcyclohexane-1,2-diamine
UP49647167287583-89-9
4-[(2,4-Dichloro-5-methoxyphenyl)amino]-7-fluoro-6-methoxy-3-quinolinecarbonitrile
UP672107103622369-46-4
WAY-262611
UP6224617681123231-07-1
2,2-Difluoropropan-1-amine hydrochloride
UP889430135868241-48-9
BAY 65-1942
UP852343697600734-02-9
(3aR,7aR)-Hexahydroisobenzofuran-1,3-dione
UP34652681271749-03-6
Corylifol A
UP338159579775351-88-7
Lithium 3-morpholinopropanoate
UP9323656231624261-85-3
3-Iodo-6-nitro-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole
UP317049390886230-74-6
LY2409881
UP924654971946518-61-2
FCCP
UP334935594370-86-5
AMG-47a
UP182829334882663-88-9
Dofequidar fumarate
UP117315546153653-30-6
CB-5083
UP8871540051542705-92-9
AMISULPRIDE
UP96579569271675-85-9
CH5132799
UP6380427541007207-67-1
LDK378 Dihydrochloride
UP4172904891380575-43-8
N-Methylhydroxylamine hydrochloride
UP5878736834229-44-1
Esomeprazole
UP785875233119141-88-7
(-)-MK 801 Maleate
UP202786085121917-57-5
GSK1838705A
UP7951594701116235-97-2
LDE225 Diphosphate
UP2685512431218778-77-8
Benzyl 2,2,2-trichloroacetimidate
UP21713484381927-55-1
Fluvoxamine Maleate
UP94558631261718-82-9
OTSSP167 hydrochloride
UP6560875171431698-10-0
PS-1145
UP654964539431898-65-6
INK-128
UP2146353221224844-38-5
Esomeprazole potassium
UP339202745161796-84-5
LDN-57444
UP474060389668467-91-2
6-Iodo-1H-indazole-3-carbaldehyde
UP479369473885518-80-9
(-)-Blebbistatin
UP745702649856925-71-8
TAK-438 free base
UP161331384881681-00-1
KS176
UP2197429221253452-78-6
2-(2-((4-Fluorobenzyl)thio)-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl)acetic acid
UP850776281356058-42-9
(3-Ethoxy-3-oxopropyl)triphenylphosphonium bromide
UP31510195742843-94-7
Cediranib
UP931648314288383-20-0
BCX 1470
UP379441809217099-43-9
Fmoc-D-Ala-OH
UP46433626779990-15-1
E-6446
UP8604225311219925-73-1
3-Ethynylimidazo[1,2-b]pyridazine
UP290812083943320-61-4
Su5205
UP2472844563476-86-6
IKKε-IN-1
UP7372008501292310-49-6